26 June 2026
by Dr. Pranab Gyawali | 14 days ago
#CrohnsDisease #UlcerativeColitis #Probiotics Next-generation probiotics may eventually become targeted microbiome treatments for Crohn’s disease and ulcerative colitis. I’m closely tracking engineered E. coli Nissle 1917 TTR, MB310 and SER-603, not because probiotics are automatically beneficial, but because these newer approaches are being designed and studied for specific biological effects...
